Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Intravitreal Melphalan for Intraocular Retinoblastoma
Protocol ID
ARET2121
Disease (Sub Disease)
Retinoblastoma
Diagnosis Stage
Newly diagnosed
Sponsor
Children's Oncology Group
Links
External Registry ≫
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 18 Years
International registry ID's
NCT05504291
Back to Registry
Study Title Intravitreal Melphalan for Intraocular Retinoblastoma
Protocol ID ARET2121
Disease (Sub Disease) Retinoblastoma
Diagnosis Stage Newly diagnosed
Sponsor Children's Oncology Group
Links https://clinicaltrials.gov/ct2/show/NCT05504291
Trial Status Preparing to Open
Study Type Treatment
Phase Phase 2
Age Eligibility up to 18 Years
International registry ID's NCT05504291